Edarbi (Arbor Pharmaceuticals)
Welcome to the PulseAid listing for the Edarbi drug offered from Arbor Pharmaceuticals. This Angiotensin 2 Type 1 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Decreased Blood Pressure [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Arbor Pharmaceuticals |
NON-PROPRIETARY NAME: | Azilsartan kamedoxomil |
SUBSTANCE NAME: | AZILSARTAN KAMEDOXOMIL |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Angiotensin 2 Type 1 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Decreased Blood Pressure [PE] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2013-02-01 |
END MARKETING DATE: | 0000-00-00 |
Edarbi HUMAN PRESCRIPTION DRUG Details:
Item Description | Edarbi from Arbor Pharmaceuticals |
LABELER NAME: | Arbor Pharmaceuticals |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 40(mg/1) |
START MARKETING DATE: | 2013-02-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 60631-040_8f4a2c09-d658-47df-b01a-cc049b206fa6 |
PRODUCT NDC: | 60631-040 |
APPLICATION NUMBER: | NDA200796 |
Other AZILSARTAN KAMEDOXOMIL Pharmaceutical Manufacturers / Labelers: